Prevnar, the first pneumococcal vaccine for children under 2
The FDA just approved Prevnar, the first pneumococcal vaccine for children under 2.
This is important. Children under 2 have the highest risk of invasive pneumococcal disease.
Prevnar targets seven strains of pneumococcus. These strains account for approx 80% of invasive disease in children under 6.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote